共 326 条
[1]
Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
[2]
Miller KD(2016)Lung Cancer statistics Adv Exp Med Biol 893 1-19
[3]
Jemal A(2011)Mortality from cancer in Tunisia: calculating years of life lost Santé publique 23 31-40
[4]
Torre LA(2011)The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification J Thoracic Oncol 6 244-285
[5]
Siegel RL(2013)Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology J Thorac Oncol 8 823-859
[6]
Jemal A(2014)Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/international association for the study of lung cancer/association for molecular pathology guideline J Clin Oncol 32 3673-3679
[7]
Lazaar-Ben Gobrane H(2015)The 2015 World Health Organization classification of lung tumors. Impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol 10 1243-1260
[8]
Hajjem S(2014)The new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects J Thorac Dis 6 526-536
[9]
Aounallah-Skhiri H(2016)Lung cancer: developments, concepts, and specific aspects of the new WHO classification J Cancer Res Clin Oncol 142 895-904
[10]
Achour N(2013)Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients Ann Oncol 24 742-748